Aidoc scores FDA clearance for pulmonary embolism AI

By staff writers

May 15, 2019 -- Israeli artificial intelligence (AI) software developer Aidoc has received clearance from the U.S. Food and Drug Administration (FDA) for AI software that can detect and triage pulmonary embolism on pulmonary CT angiograms.

At ECR 2019, researchers from University Hospital Basel presented cases demonstrating the AI software's capacity to help manage pulmonary embolism without disrupting conventional workflows. Identifying blood flow obstructions on pulmonary CT angiograms and flagging critical exams can assist radiologists in quickly attending to time-sensitive and potentially life-threatening cases, Aidoc said.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking